Sun Pharma Canada launches WINLEVI for acne
WINLEVI is the first and only topical androgen receptor inhibitor
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
clascoterone cream
Cosmo, Glenmark signs distribution and license pacts for Winlevi in Europe, South Africa
Cassiopea will receive an upfront payment of $5 million, in addition to double-digit regulatory and sales milestones as well as…
Sun Pharma and Cosmo announce territory expansion of license and supply agreements for WINLEVI
The new agreement includes Japan, Australia, New Zealand, Brazil, Mexico and Russia
US FDA approves Winlevi, topical acne treatment from Cassiopea
Reportedly, the last FDA approval of an acne drug with a new mechanism of action (MOA) occurred nearly 40 years ago